findmyKOL
Clinical trialNCT03579602CompletedPhase 2/PHASE3Interventional

Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery

SponsorBlaze Bioscience Inc.Enrollment118Pediatric Central Nervous System Tumor
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Chlidren'S Hospital Los Angeles

    Los Angeles, California, United States

  • University of California, San Francisco

    San Francisco, California, United States

  • University of Florida Shands Hospital

    Gainesville, Florida, United States

  • Johns Hopkins University

    Baltimore, Maryland, United States

  • Children'S Hospital of Michigan

    Detroit, Michigan, United States

  • Children'S Minnesota

    Saint Paul, Minnesota, United States

  • Washington University St. Louis Children'S Hospital

    St Louis, Missouri, United States

  • St. Jude Children'S Research Hospital

    Memphis, Tennessee, United States

  • Seattle Children'S Hospital

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Nov 2018
Primary completion
1 Apr 2022
Completion
13 Jun 2022
Last update posted
27 Jun 2024
Registered enrollment
118
Registry id
NCT03579602

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.